SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875320-20-000037
Filing Date
2020-09-21
Accepted
2020-09-21 16:14:30
Documents
12
Period of Report
2020-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K vrtx-20200918.htm   iXBRL 8-K 38740
  Complete submission text file 0000875320-20-000037.txt   181415

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20200918.xsd EX-101.SCH 2508
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20200918_cal.xml EX-101.CAL 795
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20200918_def.xml EX-101.DEF 1759
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20200918_lab.xml EX-101.LAB 24275
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20200918_pre.xml EX-101.PRE 12731
7 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20200918_htm.xml XML 10599
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 201186461
SIC: 2834 Pharmaceutical Preparations